Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Gut
Published September 11, 2026
International expert panel review for the use of resmetirom and semaglutide in the management of ...
September 12, 2026
Medspoke
Medspoke
Nephrology Dialysis Transplantation (NDT)
Published September 11, 2026
00:00
--:--
Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy.
September 12, 2026
Share
Sparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy.
https://www.medspoke.co/channel_journal?id=685&tap_id=13810
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
American Journal of Kidney Diseases (AJKD)
Published September 11, 2026
Complement in Kidney Disease: Core Curriculum 2026.
September 12, 2026
Why are you reporting this TALK?